Innovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases
Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...
4 years agoInnovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases
Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...
4 years ago
Are CAR-T and TCR Therapies The Future for Cancer Patients?
Cancer represents one of the most complex diseases in the world. The vast number of cancer types that vary in pathology and response to treatment continue to pose a problem. CAR-T and TCR therapies represent the next step in developing...
4 years agoAre CAR-T and TCR Therapies The Future for Cancer Patients?
Cancer represents one of the most complex diseases in the world. The vast number of cancer types that vary in pathology and response to treatment continue to pose a problem. CAR-T and TCR therapies represent the next step in developing...
4 years ago
Preclinical Pharmacokinetics: Solving the Problems of Early-Stage Predictive Assays
Understanding the pharmacokinetic profile (PK) of a compound is critical in selecting appropriate drug candidates in preclinical studies. The challenge is to predict the PKs of compounds in humans using early-stage predictive assays in these studies. Innovations in the last...
4 years agoPreclinical Pharmacokinetics: Solving the Problems of Early-Stage Predictive Assays
Understanding the pharmacokinetic profile (PK) of a compound is critical in selecting appropriate drug candidates in preclinical studies. The challenge is to predict the PKs of compounds in humans using early-stage predictive assays in these studies. Innovations in the last...
4 years ago
Emerging therapeutic areas of clinical attention & investment opportunities
Investment opportunities have changed substantially across the life sciences and pharmaceutical industry in the last ten years. It has become obvious that areas like neuroscience and respiratory medicine require additional support due to unmet clinical needs. Investment is key to...
4 years agoEmerging therapeutic areas of clinical attention & investment opportunities
Investment opportunities have changed substantially across the life sciences and pharmaceutical industry in the last ten years. It has become obvious that areas like neuroscience and respiratory medicine require additional support due to unmet clinical needs. Investment is key to...
4 years ago
Weekly News Round-up – 16/4/21
In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public...
4 years agoWeekly News Round-up – 16/4/21
In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public...
4 years ago
Evaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
4 years agoEvaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
4 years agoInterested?
Reserve your space
